2008
DOI: 10.4269/ajtmh.2008.78.924
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Five Annual Rounds of Mass Drug Administration with Diethylcarbamazine and Albendazole on Wuchereria bancrofti Infection in American Samoa

Abstract: American Samoa began a territory-wide mass drug administration (MDA) program with diethylcarbamazine and albendazole in 2000 after baseline surveys indicated that 16.5% of 2,989 residents were infected with Wuchereria bancrofti based on tests for circulating filarial antigen. Follow-up surveys were conducted in 2001, 2003, and 2006, using convenience samples of residents of sentinel villages. Antigenemia prevalence in 2001 (11.5%) and 2003 (13.5%) showed no change. After the 2003 sentinel assessment, improveme… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
29
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 16 publications
(22 reference statements)
1
29
1
Order By: Relevance
“…Regular monitoring of the effect of the programmes is essential to evaluate the progress, to make evidence based adjustments and to ultimately end the MDAs when specified programme stopping criteria have been met [13,14]. Thorough assessments and analyses of the effect of MDAs on transmission and human infection in sentinel sites have been documented, especially from countries using the DEC/albendazole combination such as Egypt [15], Papua New Guinea [16,17], American Samoa [18,19], India [20] and Samoa [21]. Many LF endemic countries in sub-Saharan Africa are co-endemic for onchocerciasis, and due to the potential risk of DEC induced side-effects in individuals with Onchocerca volvulus infections, use a combination of ivermectin and albendazole in their MDAs for LF control.…”
Section: Discussionmentioning
confidence: 99%
“…Regular monitoring of the effect of the programmes is essential to evaluate the progress, to make evidence based adjustments and to ultimately end the MDAs when specified programme stopping criteria have been met [13,14]. Thorough assessments and analyses of the effect of MDAs on transmission and human infection in sentinel sites have been documented, especially from countries using the DEC/albendazole combination such as Egypt [15], Papua New Guinea [16,17], American Samoa [18,19], India [20] and Samoa [21]. Many LF endemic countries in sub-Saharan Africa are co-endemic for onchocerciasis, and due to the potential risk of DEC induced side-effects in individuals with Onchocerca volvulus infections, use a combination of ivermectin and albendazole in their MDAs for LF control.…”
Section: Discussionmentioning
confidence: 99%
“…The ICT positive, mf negative findings are not uncommon, 19 especially during the MDA phase of an LF elimination program. 7,25 However, a single 60 μL blood slide is less sensitive for detecting mf than are 1 mL blood filtration techniques, and true mf positives therefore may not have been identified. False negatives (mf positive, ICT negative) are unlikely given the reported high sensitivity of the ICT.…”
Section: Discussionmentioning
confidence: 99%
“…Prevalence of CFA in a baseline survey in 1999 was 16.5% [19], and subsequent testing in four sentinel villages found CFA declining from 11.5% in 2001 to 0.95% in 2006 [20]. Prevalences in an additional four villages surveyed in 2006 were higher, ranging from 2.1% to 4.6% [20], [21], and a territory-wide serosurvey in 2007 found 2.3% CFA prevalence. Additional MDA activities took place during 2007–2010, but the level of MDA coverage during those years is unclear.…”
Section: Introductionmentioning
confidence: 96%